Riann Tyree
Medical · Greensburg, KSNPI 1487277703
Payments from drug & device makers
Across 113 payments — averaging $14.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$308
- Lilly USA, LLC$267
- Novo Nordisk$262
- Sunovion Pharmaceuticals Inc.$110
- AstraZeneca$106
- Amarin Pharma, Inc.$71
- plus $565 from 19 others
What the payments were for
- Food & beverage$1,689100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 22 | $308 |
| Lilly USA, LLC | 19 | $267 |
| Novo Nordisk | 21 | $262 |
| Sunovion Pharmaceuticals Inc. | 7 | $110 |
| AstraZeneca | 8 | $106 |
| Amarin Pharma, Inc. | 3 | $71 |
| Amgen | 4 | $59 |
| Merck | 4 | $54 |
| Sanofi-aventis U.S. LLC | 3 | $49 |
| Edwards Lifesciences | 2 | $49 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Johnson & Johnson | 2 | $35 |
| Biowound Solutions, Inc. | 1 | $34 |
| Bayer | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Pfizer | 2 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Medtronic | 1 | $20 |
| Sanofi Pasteur Inc. | 1 | $19 |
| Genentech USA, Inc. | 2 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Mimedx Group, Inc. | 1 | $16 |
| GSK | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
How this compares
$1,689 in reported general payments places this provider in the 65th percentile of 205 medical providers in Kansas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 19 | $18,716 |
| Fluticasone Propionate | 24 | $490 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $488 |
| FenofibrateFenofibrate Nanocrystallized | 25 | $486 |
| Potassium Chloride | 18 | $477 |
| Pregabalin | 13 | $396 |
| Naproxen | 11 | $354 |
| Omeprazole | 42 | $321 |
| Celecoxib | 19 | $299 |
| Gabapentin | 28 | $281 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 19 | $279 |
| Atorvastatin Calcium | 45 | $273 |
| Carvedilol | 25 | $248 |
| Tamsulosin Hcl | 23 | $202 |
| Losartan Potassium | 27 | $198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $262 | $18,71619 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 205 medical providers in Kansas.
Other medical in Greensburg
- Linly StevensOverland Park$111K
- Shana ArnholdShawnee$82K
- Richard AllenbachWichita$70K
- Laura LudlowTopeka$61K
- Anita KishOlathe$58K
- Kathryn WelchWichita$32K
- Courtney SteneOverland Park$22K
- Janella DewittOverland Park$19K
- Walter DeanMission$16K
- Jason MengesWichita$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.